Article Details

China's Asymchem Biotechnology to raise $392m from Hillhouse, others - DealStreetAsia

Retrieved on: 2022-03-28 06:16:28

Tags for this article:

Click the tags to see associated articles and topics

China's Asymchem Biotechnology to raise $392m from Hillhouse, others - DealStreetAsia. View article details on hiswai:

Excerpt

Shanghai Asymchem Biotechnology Development, a wholly-owned subsidiary of China-based drug developer Asymchem Laboratories (Tianjin), ...

Article found on: www.dealstreetasia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up